Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02584452 · ClinicalTrials.gov registry record · NA
Trial Evaluating Postop Pain and Muscle Strength Among Regional Anesthesia Techniques for Ambulatory ACL Reconstruction
A NA study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 59
- Enrollment target
NCT02584452 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 59 participants.
The verdict
NCT02584452, a NA study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
Study Summary
Despite the apparent multifaceted benefit in differentiating blockade sites and duration of nerve blockade, the efficacy of continuous adductor canal blockade utilized specifically in ACL reconstruction has not been extensively studied. This study will test the hypothesis that the use of the adductor canal continuous nerve catheter will result in lower subjective pain scores on postoperative day 2 and improved quadriceps strength on postoperative day 1.
Interventions
- DRUG Mepivacaine
- PROCEDURE adductor canal continuous nerve catheter
- DRUG Normal Saline as bolus followed by bupivacaine
- PROCEDURE adductor canal nerve block
- DRUG ropivacaine and dexamethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2015-11-03 |
| Est. Completion | 2018-04-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02584452
The ClinicalTrials.gov registry entry for NCT02584452 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Mepivacaine is the first listed.
NCT02584452 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02584452 about?
NCT02584452 is a clinical study titled "Trial Evaluating Postop Pain and Muscle Strength Among Regional Anesthesia Techniques for Ambulatory ACL Reconstruction". Despite the apparent multifaceted benefit in differentiating blockade sites and duration of nerve blockade, the efficacy of continuous adductor canal blockade utilized specifically in ACL reconstruction has not been extensively studied. This study will test the hypothesis that the use of the adducto...
What is the current status of trial NCT02584452?
This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2015-11-03. Estimated completion is 2018-04-10.
What interventions are being tested in trial NCT02584452?
The interventions under investigation include: Mepivacaine (DRUG), adductor canal continuous nerve catheter (PROCEDURE), Normal Saline as bolus followed by bupivacaine (DRUG), adductor canal nerve block (PROCEDURE), ropivacaine and dexamethasone (DRUG).
Who is sponsoring clinical trial NCT02584452?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.